Several noninvasive fibrosis scoring systems comprised of routinely measured clinical and laboratory variables have been developed in adult patients with NAFLD to identify those with advanced fibrosis including the AST/ALT ratio, NAFLD fibrosis score (NFS), the AST/platelet ratio index (APR), and the FIB4-score [5]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.